SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.

Cell
Gizem DonmezLeonard Guarente

Abstract

A hallmark of Alzheimer's disease (AD) is the accumulation of plaques of Abeta 1-40 and 1-42 peptides, which result from the sequential cleavage of APP by the beta and gamma-secretases. The production of Abeta peptides is avoided by alternate cleavage of APP by the alpha and gamma-secretases. Here we show that production of beta-amyloid and plaques in a mouse model of AD are reduced by overexpressing the NAD-dependent deacetylase SIRT1 in brain, and are increased by knocking out SIRT1 in brain. SIRT1 directly activates the transcription of the gene encoding the alpha-secretase, ADAM10. SIRT1 deacetylates and coactivates the retinoic acid receptor beta, a known regulator of ADAM10 transcription. ADAM10 activation by SIRT1 also induces the Notch pathway, which is known to repair neuronal damage in the brain. Our findings indicate SIRT1 activation is a viable strategy to combat AD and perhaps other neurodegenerative diseases.

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B BlumbergE M De Robertis
Dec 1, 1985·Neurochemical Research·S S PanterW H Frey
Dec 15, 1995·Cell·D J Mangelsdorf, R M Evans
Jan 31, 2002·Journal of Molecular Neuroscience : MN·D HartmannB De Strooper
Dec 17, 2002·Molecular and Cellular Biology·Michael W McBurneyMadeleine Lemieux
Feb 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ann B Goodman, Arthur B Pardee
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hwei-Ling ChengKatrin F Chua
Jan 27, 2004·The American Journal of Pathology·Hiroaki FukumotoMichael C Irizarry
Aug 13, 2004·The European Journal of Neuroscience·Jonathan P T CorcoranMalcolm Maden
Feb 16, 2005·Sub-cellular Biochemistry·Elzbieta Kojro, Falk Fahrenholz
Mar 8, 2005·Neurobiology of Aging·Nilay V PatelCaleb E Finch
May 17, 2005·Mechanisms of Ageing and Development·David A Sinclair
May 27, 2005·Nature Neuroscience·Keejung Yoon, Nicholas Gaiano
Jun 1, 2005·Trends in Neurosciences·Rui M CostaAlcino J Silva
Jun 24, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claudia PrinzenRolf Postina
Mar 17, 2006·Nature·Sylvain LesnéKaren H Ashe
Jan 20, 2007·Genes, Brain, and Behavior·R S ReisererM P McDonald
Sep 20, 2007·Aging Cell·Laura BordoneLeonard Guarente
Jan 16, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Frank TippmannFalk Fahrenholz
Apr 22, 2009·Cell·Raphael Kopan, Maria Xenia G Ilagan
Apr 22, 2009·Molecular and Cellular Biochemistry·Sandra Isabel VieiraOdete A B da Cruz e Silva
Jun 6, 2009·Science·Leonard Guarente
Sep 4, 2009·The Journal of Biological Chemistry·Geert van TeteringMarc Vooijs
Dec 17, 2009·Genes & Development·Dena E CohenLeonard P Guarente
Apr 23, 2010·Aging Cell·Gizem Donmez, Leonard Guarente

❮ Previous
Next ❯

Citations

Oct 5, 2011·Experimental Brain Research·Kristina Endres, Falk Fahrenholz
Nov 29, 2011·Experimental Brain Research·Johannes ProxPaul Saftig
Apr 26, 2013·Molecular Neurobiology·Alanna Fernandes ParaísoSergio Henrique Sousa Santos
Oct 18, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yue-Qiang ZhaoVictoria V Lunyak
Apr 30, 2013·Neuropharmacology·Kazuyoshi KitaokaKazuo Yoshizaki
Sep 8, 2010·Cell Research·Silvia Bicker, Gerhard Schratt
May 22, 2013·Cell Research·Adrianna Z Herskovits, Leonard Guarente
May 7, 2013·Nature Cell Biology·Victoria A RafalskiAnne Brunet
Aug 8, 2012·Nature Medicine·Mira Jakovcevski, Schahram Akbarian
Apr 12, 2011·Nature Neuroscience·Pilar EstevePaola Bovolenta
Nov 20, 2012·Nature Neuroscience·Luca TiberiPierre Vanderhaeghen
Nov 26, 2010·Nature Reviews. Cancer·Daniel Herranz, Manuel Serrano
Jun 2, 2012·Nature Reviews. Drug Discovery·Joseph A BaurRafael de Cabo
Oct 6, 2010·Nature Reviews. Genetics·Sarah E Johnstone, Stephen B Baylin
Jun 10, 2011·The New England Journal of Medicine·Leonard Guarente
Dec 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Salvatore FuscoGiovambattista Pani
Oct 15, 2011·The Journal of Biological Chemistry·Rita CostaIsabel Cardoso
Oct 23, 2012·The Journal of Biological Chemistry·Carlos SebastiánRaul Mostoslavsky
May 20, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dorothea RatElzbieta Kojro
Nov 15, 2011·Current Opinion in Oncology·John R P Knight, Jo Milner
Feb 14, 2012·Current Opinion in Psychiatry·Nady BraidyPerminder S Sachdev
Oct 12, 2013·Genes & Development·Leonard Guarente
Nov 23, 2011·Pharmacological Reviews·Carles Cantó, Johan Auwerx
Jul 20, 2012·Physiological Reviews·Ruben NogueirasMatthias H Tschöp
Sep 24, 2011·Oxidative Medicine and Cellular Longevity·Ke XuZhao-Feng Jiang
Feb 9, 2012·Current Gerontology and Geriatrics Research·Stephan P PersengievRonald E Bontrop
Dec 20, 2012·International Journal of Alzheimer's Disease·Gizem Donmez
Jan 12, 2013·Dementia and Geriatric Cognitive Disorders·Patricia Regina ManzineSofia Cristina Iost Pavarini
Aug 21, 2012·Circulation Research·Maha Abdellatif
Mar 5, 2013·The Journal of Clinical Investigation·Jessica A HallPere Puigserver
Apr 30, 2011·Molecular Neurodegeneration·Hui Zheng, Edward H Koo
Dec 6, 2012·Translational Neurodegeneration·Yang Hong-QiChen Sheng-Di
Mar 8, 2011·Journal of Cell Science·Takashi Nakagawa, Leonard Guarente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.